Rhamnoside from Aquilaria sinensis leaves ameliorates chronic atrophic gastritis via immunomodulation and apoptosis regulation
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-13102-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 03.11.2026. Verfasst von Weihua Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi Province, China. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Thymelaeaceae. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Chronic atrophic gastritis (CAG) is a precancerous inflammatory‑atrophic gastric disorder with limited effective therapies. Although Traditional Chinese medicine shows multi‑target benefits for CAG, the bioactivity of rare medicinal plant Aquilaria sinensis remains poorly understood. This study aimed to identify anti‑inflammatory components from Aquilaria sinensis leaf extract and clarify the compound's anti‑CAG effects and mechanism. METHODS: Anti‑inflammatory constituents were screened. Macrophages stimulated by LPS and MNNG‑injured GES‑1 cells were used to assess cell viability, inflammation, cell‑cycle, proliferation and apoptosis. Transcriptomic‑proteomic profiling predicted candidate pathways. An MNNG‑combined rat CAG model was established; gross gastric observation, H&E, AB‑PAS, Masson staining, immunofluorescence, immunohistochemistry and qPCR were performed. RESULTS: rhamnoside exhibited the strongest anti‑inflammatory activity. It reduced IL‑1β, IL‑6 and TNF‑α secretion and suppressed apoptosis in LPS‑treated macrophages, and triggered S‑phase cell‑cycle arrest in MNNG‑damaged GES‑1 cells. Omics analyses pinpointed PI3K/Akt as the core regulatory pathway. In vivo animal experiments demonstrated that rhamnoside dose‑dependently alleviated gastric gland atrophy, intestinal metaplasia and lamina propria fibrosis; it elevated PI3K/Akt signals, down‑regulated pro‑apoptotic BAX/caspase‑3, up‑regulated anti‑apoptotic BCL‑2, and normalized CAG‑associated gene transcription in gastric mucosa. CONCLUSION: Rhamnoside from Aquilaria sinensis leaves protects against CAG by regulating immunity and inhibiting apoptosis via PI3K/Akt signaling, which provides a potential candidate for CAG experimental therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi Province, China.
- Department of Pharmacy, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi Province, China. crisxy@126.com.
Zitieren
APA
Zhang, W., Yue, B., Zhi, Y., Lv, N., Sun, D., Wang, Y., & Wang, X. (2026). Rhamnoside from Aquilaria sinensis leaves ameliorates chronic atrophic gastritis via immunomodulation and apoptosis regulation. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13102-0
Vancouver
Zhang W, Yue B, Zhi Y, Lv N, Sun D, Wang Y, et al. Rhamnoside from Aquilaria sinensis leaves ameliorates chronic atrophic gastritis via immunomodulation and apoptosis regulation. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13102-0
BibTeX
@article{Zhang2026,
author = {Zhang, Weihua and Yue, Baosen and Zhi, Yuan and Lv, Nan and Sun, Dan and Wang, Yalan and Wang, Xiayin},
title = {Rhamnoside from Aquilaria sinensis leaves ameliorates chronic atrophic gastritis via immunomodulation and apoptosis regulation},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-13102-0}
}
EUVIMED